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Background. Prior to organ harvesting, an attempt 
was made to modulate the donor's immune responses 
against prospective xenogeneic recipients by infusion 
of "recipient-type" bone marrow. 
Methods. For this purpose, baboons conditioned 
with total lymphoid irradiation were given 6x 108 un-
modified human bone marrow cellslkg body weight 
with no subsequent treatment. 
Results. Animals survived until they were eutha-
nized at 18 months. Using primers specific for human 
chorionic gonadotrophin gene, the presence of human 
DNA was confirmed by polymerase chain reaction in 
the blood of one animal for up to 18 months after cell 
transplantation; in the other animal, xenogeneic chi-
merism became undetectable in the blood at 6 months 
after bone marrow infusion. However, tissue samples 
obtained from both animals at the time they were eu-
thanized had evidence of donor (human) DNA. Addi-
tionally, the presence of donor DNA in individually 
harvested colonies of erythroid and myeloid lineages 
• suggested that infused human bone marrow cells had 
en grafted across the xenogeneic barrier in both ba-
boons. 
Conclusions. Bone marrow transplantation from hu-
man to baboon leads to establishment of chimerism 
and modulation of donor-specific immune reactivity, 
which suggests that this strategy could be reproduc-
ibly employed to create "surrogate" tolerogenesis in 
prospective donors for subsequent organ transplanta-
tion across xenogeneic barriers. 
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Insight into the probable mechanisms of allograft and, by 
inference, xenograft acceptance has been provided by the 
recent discovery of persistent ubiquitous donor cells in long-
surviving human organ recipients (1,2). It has been demon-
strated in humans and in experimental models that these 
donor cells seeded from the transplanted organ are multilin-
eage "passenger leukocytes~ of bone marrow (BM*) origin 
and include stem cells (3, 4). We have postulated that the 
commingled donor-recipient immunocyte populations pro-
gressively become mutually nonreactive (tolerant). Their re-
ciprocal nullification may explain why major histocompati-
bility complex-disparate organs of all kinds (1, 2) and 
unaltered donor BM can be safely engrafted in noncytoab-
lated recipients without causing graft-versus-host disease 
(GVHDl (5, 6). 
We report here observations suggesting that the two-way 
paradigm will be relevant in strategies for xenotransplanta-
tion. Unmodified human BM cells were infused into baboons 
that had been conditioned by total lymphoid irradiation 
(TLl). Although TLI is cytoreductive. it leaves the recipient 
arm of the two-way paradigm partially intact, with a conse-
quent low incidence of GVHD. Unequivocal evidence was 
obtained of xenoengraftment and maintenance of long-term, 
widespread. multilineage human leukocyte chimerism with-
out GVHD or other adverse effects. 
Three healthy juvenile baboons (Papio anubis) were ob-
tained from the Southwest Foundation for Biomedical Re-
search (San Antonio. TX) and housed at the Montefiore Hos-
pital, University of Pittsburgh Medical Center. This is an 
American Association for Accreditation of Laboratory Animal 
Care approved facility. The animals were quarantined and 
rigidly screened for viral and microbial infections before and 
after arrival in Pittsburgh. After induction of anesthesia with 
ketamine (10 mg/kg i.m.; Parke-Davis, Morris Plains, NJ), 
maintenance supplementation with isoflurane (FORANE, 
Omega, Liberty Corner. NJ), and endotracheal intubation, 
two of the baboons were submitted to 750 cGy ofTL! (cobalt-
60; Eldorado 78 Teletherapy Unit. AECL, Ottawa, Canada); 
the lungs, liver, head. and limbs were spared. The third 
* Abbreviations: BM. bone marrow; GVHD, graft-versus-host dis-
ease; MLR. mixed leukocyte reaction; PBMC, peripheral blood mono-
nuclear cells; PCR, polymerase chain reaction; TLI, total lymphoid 
irradiation. 
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animal, which received 750 cGy of total body irradiation, died 
from BM aplasia after 14 days and will not be discussed 
further. 
Immediately after the TLI, 6x 101l/kg unmodified human 
BM cells were infused into the baboons through an intrave-
nous catheter placed in the femoral vein. with no change in 
vital signs. The cryopreserved BM cells had been procured 
from 32- and 10-year-old cadaveric human donors, as de-
scribed elsewhere (5). The animals were administered pro-
phylactic therapy for Candida. Gram-negative bacteria, and 
herpes virus. The two animals (MIa and MIl) treated with 
TLI appeared healthy throughout the course of the experi-
ments and showed no signs of GVHD. After 18 months, both 
were euthanized with an overdose of sodium pentobarbital 
(Abbott Laboratories, Chicago, ILl. 
Evidence of donor leukocyte chimerism was sought in pe-
ripheral venous blood samples 3. 6, and 12 months after 
reconstitution, and in blood and multiple tissue samples col-
lected at the time the two animals were euthanized at 18 
months. Chimerism was looked for in the baboon blood and 
tissue samples, using immunohistochemical and polymerase 
chain reaction (PCR) technologies, The immunohistochemi-
cal and flow cytometric analysis yielded inconclusive results 
because monoclonal antibodies directed against either donor 
HLA class I or human CD45 (pan-leukocyte markerl cell 
surface antigens exhibited marked cross· reactivity with ba-
boon cells. This observation was confirmed by a microlym-
phocytotoxicity assay <Biotest AG. Dre!elch. Germany) and 
Terasaki second HLA 72 well tray I lot 11. One Lambda, Inc., 
Canuga Park, CAl. 
Consequently, we depended exclusivelv on PCR for the 
determination of chimerism. USlOg probes directed against 
the human chorionic gonadotropm gene. Primers (5' AAC-
CCCGTGGTCTCCTACG-3' and 5' rrGGAGGATCGGGGT-
GTCC-3') were selected from the middle exon of the l3-sub-
unit of human chorionic gonadotroplO. and were specific for 
humans and failed to amplify the corresponding baboon se-
quence. The specificity of the method was established by 
amplificatIOn of DNA obtained from the peripheral blood 
mononuclear cells (PBMC) of the normal healthy humans 
and baboons that served as positIve and negative controls. 
respectively. Fresh or frozen vertebral B~l cells and PBMC 
were examined. In addition to direct examination of these 
specimens. the PCR assay also was used to detect the pres-
ence of human cells in colonies obtalOed from hematopoietic 
progenitor cell assays. 
All other tissues were fixed in formalin at the time of 
euthanasia, necessitating formaldehyde extraction before 
DNA purification. This was achieved by placing a small piece 
of the tissue into a seamless cellulose dialysis tubing (cut-off, 
12 kDa) which was subsequently dialyzed for 12 hr at room 
temperature against 4 L ofbutl'er (10 mM Tris HCI and 1 mM 
EDTA [pH 8.0]). After two sets of hot-start PCR amplifica-
tions (35 cycles/setl. the products were resolved by electro-
phoresis on an agarose gel and visualized using ethidium 
bromide staining. To preclude false positive or negative re-
sults, comparably aged (in formaldehyde) fixed tissue sam-
ples (liver) obtained from normal humans and baboons were 
used as appropriate controls. Additionally, to rule out con-
tamination. three independent sets of molecular analysis 
were performed on freshly isolated DNA. The sensitivity of 
the PCR assay was 10-2 (1:1001. 
Evidence for human cell engraftment was obtained by he-
matopoietic progenitor cell assays. When the baboons were 
euthanized, their vertebral columns were resected en bloc for 
subsequent isolation of the BM cells that were used in this 
assay. A known concentration of cells (2x 105 ) was suspended 
in Metho Cult GF H4434 medium (Stem Cell Technologies, 
Vancouver, BC) and dispensed in triplicate into 1 ml of tissue 
culture plates and incubated for 14 days at 37°C in 5% CO2 
in air. At the end of incubation, colonies of burst-forming 
unit-erythroid (BFU-E), colony-forming unit-granulocyte 
and macrophage (CFU-GM), and granulocyte colony-forming 
unit-granulocyte-erythroid, megakaryocyte, and macro-
phage (CFU-GEMM) were scored. PCR was used to identify 
handpicked colonies that had donor DNA. 
To assess recipient's immunocompetence, a one-way mixed 
leukocyte reaction (MLR) was performed with the PBMC 
obtained from the chimeric baboons at the time they were 
euthanized. A constant dose (5X104 cells/well) of freshly iso-
lated baboon PBMC (used as responders) was co-cultured for 
6 days at 37°C with equal numbers of gamma-irradiated (20 
Gy), cryopreserved, third-party human splenocytes (used as 
stimulators) in a 96-well, round-bottom microtiter plate (Bec-
ton Dickinson, Lincoln Park, NJ) in 5% CO2 in air. For the 
fInal 20 hr, 1 /-LCi of [3Hl-thymidine (NEN, Boston, MA) was 
added to each well and its degree of incorporation was deter-
mined by liquid scintillation counting. As controls, responses 
of M10 and Mll PBMC were determined against gamma-
irradiated autologous and allogeneic (baboon) PBMC. Re-
sults were expressed as mean counts per minute (cpm). 
Serial blood samples were also obtained to ascertain the 
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FIGURE 1. (A) PCR analysis of BM and PBMC obtained from ani-
mals (MIO and Mll) at the time they were euthanized (18 months 
after reconstitution). Amplification was performed using primers 
specific for the 203-basepair segment of the human chorionic gona-
dotropin gene, and the products were resolved by electrophoresis on 
a 1.5% agarose gel (see text). The banda were visualized using 
ethidium bromide staining. DNA obtained from the PBMe of normal 
human and baboon served as positive and negative controls, respec-
tively (arrow: 203-basepair product of interest). (B) Detection of 
human DNA in formaldehyde-fixed-dialyzed tissues obtained at the 
time of death (18 months after transfusion) from two baboons 
li: MIO; ii: MIl) who underwent cytoreductive conditiOning with TLI 
before reconstitution with human BM. For controls (ill), same-aged 
(in formaldehyde), flXed-dialYZed tissue (liver) obtained from normal 
human and baboon were used as positive and negative controls. 
respectively (arrow: 203-basepair product of interest). 
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TABLE 1. Detection of donor (human) DNA in the colonies 
obtained from hematopoietic progemtor cell assays I HPCA) 
generated from baboon BM cells harvested at the time of deatha 
Animals 
MlO 
Mll 
BM cells 
BFU-E 
+ 
+ 
HPCA" 
lDcr·d~l \'FU·GEMM 
+ 
+ 
Q Animals were euthanized 18 months after reconstitution. 
b BFU-E, burst-forming unit-erythroid; CFU·GM. colony-forming 
unit-granulocyte-macrophage; CFU-GEMM, colony-forming unit-
granulocyte-erthyroid megakaryocyte-macrophage. 
presence of donor cells by PCR. In one baboon (Mll), donor 
(human) DNA was detectable in all peripheral blood speci-
mens, whereas in baboon MI0, it was not found in the 12-
month blood samples, However. human DNA was found in 
the blood. BM (Fig. lA), and all tissue samples (Fig. 1B [ill 
obtained at the time baboon MlO was euthanized, with the 
exception of muscle. This distribution of donor DNA was as 
impressive as that in baboon MIL in whom all specimens 
taken at death (except lung) were pOSitive (Fig. IB [iiJl. 
Furthermore, as presented in Table 1. donor DNA was 
present in individually harvested colonies of BFU-E, CFU-
GM, and CFU-GEMM, thereby confirming stem cell engraft-
ment. It should be noted that human cytokines were used for 
the generation of these colonies. which allowed for relatively 
preferential expansion of hematopoietIc stem cells of human 
origin. Additionally, moderate proliferative activity was also 
evident in cells obtained from naive baboons when cultured 
under similar conditions, which suggests the partial cross-
reactivity of the bIOlogical effects of these cytokines. How-
ever, despite these observations, no attempt was made to 
ascertain the proposition of colonies of vanous origin, thus 
obviating the determination of the level of human xenochi-
mensm. 
These tindings indicate that under the appropriate circum-
stances. chimerism can be readily and safely induced across 
the human --+baboon barrier. Although we were Initially sur-
pnsed. this was consistent with prevIOus observations that 
isolated xenogeneic cells do not undergo hyperacute rejection 
even when transplanted from disparate species whose whole 
organs undergo Infarction immediately after revasculariza-
tion by surgical anastomosis Isummanzed In [7]1. Addition-
ally, using one-way MLR assays, both animals were found to 
be immunocompetent, exhibiting responses against alloge-
neic Ibaboon) and xenogeneic third-party (human) stimula-
tors I Fig. 2). Incidentally, the nonavallability of donor spleno-
cytes and preirradiation PBMCs from the BM recipients 
precluded any meaningful evaluation of donor-specific immu-
nomodulation in these animals. 
With the genetically closer circumstances ofbaboon-+human 
transplantation. organs are not abruptly rejected (7). However, 
a ~slow motion" version of hyperacute rejection occurs, despite 
complete control of cellular rejection (7); in the best-studied 
cases. there was unmistakable evidence of complement activa-
tion (7). Consequently, we have concluded that more drastic 
modification of both the xenograft;s and their recipients will be 
necessary for long-term engraftment. even using concordant 
species (7). The studies reported here were designed to explore 
that poSSibility. 
Most clinically oriented organ xenotransplantation re-
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FIGURE 2. A one-way MLR was performed using freshly isolated 
PBMC (5 x 104 cells/well) obtained from chimeric baboons at the time 
they were euthanized (18 months after reconstitution) as responders 
with an equal number of gamma-irradiated cells obtained from var-
ious source used as stimulators. Stimulators: (.) autologous PBMC, 
E~F third-party human splenocytes, ([0) allogeneic (baboon) PBMC. 
The results are expressed as mean of [3Hl-thymidine incorporation. 
search (7) has focused on preventing complement activation 
directly by removing its precipitating cause (i.e., xenogeneic 
antibodies) or by making the organ xenograft a less vulner-
able target (e.g., the creation of transgenic donors) (8-10). 
Even if successful. these approaches will be only a first step 
in breaching the genetic barrier of xenotransplantation. 
The experiments reported herein could have clinical impli-
cations for the next step. The two TLl-conditioned adult 
baboons given human BM developed persistent human leu-
kocyte chimerism. with evidence suggesting the possibility of 
stem cell engraftment. Striking evidence for the presence of 
donor DNA was found in most of the organs commonly trans-
planted clinically. The ability to induce coexisting xenogeneic 
donor and recipient leukocyte populations in parenchymal as 
well as hematolymphopoietic organs may allow various sub-
sequent manipulations (e.g., adoptive transfer of chimeric 
marrow and/or xenotransplantation of the chimeric organs 
[11]). 
It is noteworthy that the achievement of stable transpecies 
donor leukocyte chimerism is not limited to closely related 
species. Zanjani et a1. (12) have successfully produced stable 
multiline age human donor leukocyte chimerism in sheep by 
inoculation of fetuses early in gestation with stem cells pu-
rified from adult human BM and with nonparenchymal cells 
from livers of aborted human fetuses. The humanized and 
ostensibly normal sheep (now 7 years old) have been a prime 
source of stem cell-rich chimeric BM that has been adoptively 
transferred to fetuses. Similar observations have also been 
made in baboon-+pig BM chimeras (I1). Neonatal pigs who 
received unaltered baboon BM cells had unequivocal evi-
dence for the presence of donor cell chimerism in their pe-
ripheral blood and BM for up to 17 months after infusion. 
Additionally, there was evidence for induction of stable do-
1598 TRANSPLANTATION Vol. 64, No. 11 
nor-specific immune modulation as detennmed by in vitro 
MLR assays (1 n 
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IMPROVED TECHNIQUE OF HETEROTOPIC CERVICAL HEART 
TRANSPLANTATION IN MICE1,2 
YUKIHIRO TOMITA,3.4 QI·WEI ZHANG,3 MASAHlRO YOSHIKAWA,5 TAKAYUKI UCHIDA,3 Kumo NOMOTO,5 
AND HISATAKA YASUI3 
[)epartml'nt of CardIOvascular Surgery. Faculty of Medicine. and Department of Immunology. 
Medical institute of Bioregulation. Kyushu University. Fukuoka 812-82. Japan 
Background. The method for mouse vascularized 
heart transplantation have been described using su-
ture and cuff techniques_ Technical problems have 
limited its widespread use. Here, we describe our 
method of modified cervical beterotopic transplanta-
tion with the cuff technique. 
Methods. By using a smaller Teflon cuff <external 
diameter 0.6 mm, internal diameter 0.4 mm) and su-
perfine-tip forceps, it became possible to directly pull 
the edge of the carotid artery and evert the proximal 
end of the artery over the cuff. Similarly, the external 
jugular vein could be easily everted over a 22-gauge 
cuff with this direct pulling method. 
Results. By these modifications. the operation time 
was reduced. It usually takes 20 min for the donor 
harvest. 15 min for preparation of the cervical vessels. 
and 15 min for anastomosis. All procedures from the 
donor harvest through skin closure of the recipient 
1 This study was supported by a Grant-in-Aid (Y.T.) for Scientific 
Research from the Ministry of Health and Welfare, Japan, and the 
Naito Foundation (Y.T.). 
2 All procedures were recorded and edited on Videotape (8 min, 
VH8 or 8VH8)' A videotape can be sent to the reader upon request 
ta the corresponding author. 
3 Department of Cardiovascular Surgery. 
• Address correspondence to: Yukihiro Tomita, M.D., Ph.D., Assis-
tant Professor. Department of Cardiovascular Surgery, Faculty of 
:'viedicine. Kyushu University, Fukuoka B12-82, Japan. 
S Department of Immunology. 
mice can be completed within 1 hr. and ischemic time 
is within 25-40 min. 
Conclusions. This method can be used to investigate 
cyclophosphamide-induced tolerance and mecha-
nisms of reperfusion injury. 
The technique for heterotopic heart transplantation in 
mice was first described by Corry et aL in 1973 (1). Although 
this model has been used in some laboratories to study the 
immunology of graft rejection (2, 3), technical problems as-
sociated with the anastomosis of small vessels seem to have 
limited its widespread use. On the other hand, Matsuura et 
aL (4) reported a method of cervical heterotopic heart trans-
plantation using the cuff technique. Although they stated 
that their method was easier than other methods. their 
method still has technical problems. To greater reduce oper-
ating time and make this cuff technique easier, we have 
developed a more simplified method of heterotopic cervical 
heart transplantation. 
Female C3H1He SIc (H2k) mice were bred and maintained 
at the Institute of Experimental Animals, Kyushu Univer-
sity, Fukuoka, Japan. Female AKRJJ Sea (H2k) mice were 
obtained from the Seiwa Experimental Animal Institute, 
Oita, Japan. Recipients were used at 12-16 wk of age. 
The mice were anesthetized with pentobarbital at 0.5 mg! 
mg. An operating microscope with 20 times magnification 
(OME-JA; Olympus Inc .• Tokyo, Japan) was used for the 
procedure. Operations were performed by a single surgeon 
